However, this treatment is specifically for children with comorbid anxiety disorders and does not target
the core autism symptoms or underlying neurocognitive deficits.
However, when we examined the overall estimated probability of meeting «caseness» on the GHQ - 12, neither child
core autism symptoms (social affect and restrictive and repetitive behaviours), nor child level of speech, were associated with caregiver mental health difficulties.
Treatment options seem just as vague, with no drug treatments developed specifically for
core autism symptoms.
Not exact matches
«We have discovered a small molecule compound that shows a profound and prolonged effect on
autism - like social deficits without obvious side effects, while many currently used compounds for treating a variety of psychiatric diseases have failed to exhibit the therapeutic efficacy for this
core symptom of
autism,» said Zhen Yan, PhD, professor in the Department of Physiology and Biophysics in the Jacobs School of Medicine and Biomedical Sciences at UB, and senior author on the paper.
There is no Food and Drug Administration - approved medical treatment for the
core symptoms of
autism spectrum disorder, a lifelong neurodevelopmental condition whose hallmarks are deficits in social relatedness, repetitive thoughts and behaviors and, often, intellectual disability.
«Right now we have no medications treating the
core symptoms of
autism.
At Caltech, developmental neurobiologist Paul Patterson found he could induce the
core symptoms of
autism and schizophrenia in mice by giving their mothers the flu during pregnancy, or by arousing their immune systems in utero with an injection of foreign RNA.
«We don't have a lot of medications for the
core symptoms of
autism — arguably we have none,» says Thomas R. Insel, director of the National Institute of Mental Health.
Autism spectrum disorders share three
core symptoms: impaired sociability, repetitive behaviors and communication deficits.
Problems with communication, specifically non-verbal cognitive ability, are a strong predictor of externalising behaviour problems.3 Children with ASD exhibit more severe internalising and externalising behaviours than non-ASD children, as well as a high prevalence of aggressive behaviour.3 These behavioural challenges can often cause caregivers more distress and mental health problems than the
core ASD
symptoms.4, 5 Increased child behaviour problems and parental (especially maternal) psychological distress compared with children without
autism is established early in life — by the time that children are aged 5 years.6 These co-occurring, behaviour problems are of concern in early childhood because of the importance of these early years for longer term child developmental outcomes.7
These include «
core»
autism symptoms (e.g. social communication impairments, interfering restrictive / repetitive behaviours), but also poor cognitive and adaptive skills, and the emotional and behavioural difficulties that are frequently co-occurring features.
As a measure of parenting stress specific to
core and co-morbid
symptoms of
autism, the APSI is unique.